We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Mouse Model for Study of Neurodegenerative Proteins

By Biotechdaily staff writers
Posted on 11 Nov 2003
Researchers have established a mouse model that allows them to study two proteins, p25 and cyclin-dependent kinase 5 (Cdk5), which are involved in the neuronal death and atrophy found in neurodegenerative diseases.

The long-lived p25 protein is generated in the brain by proteolytic cleavage of the p35 protein. P25 activates Cdk5, and this combination has been found in the brain tissue of patients with neurodegenerative diseases such as Alzheimer's and Niemann-Pick type C. Investigators from Harvard Medical School (Boston, MA, USA) developed a line of mice with a gene for overproduction of p25. Expression of the gene was suppressed during brain development with doxycycline. The drug was removed when the mice matured, and the effects of p25 overexpression were determined.

Results published in the October 30, 2003, issue of Neuron showed that after only 12 weeks of p25 exposure, neuronal density in the mouse brains declined by 40%. By 30 weeks after p25 induction, aggregation of tau proteins caused neurofibrillary tangles in the brain, along with neurodegeneration and neuronal cell death.

"This is an excellent animal model for any therapeutic approach toward p25 and its link to Alzheimer's and similar neurodegenerative diseases,” explained senior author Dr. Li-Huei Tsai, professor of pathology at Harvard Medical School. "We know that p25 causes neurodegeneration, and we want to figure out how that mechanism works.”




Related Links:
Harvard Medical School

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood

Latest BioResearch News

Genetic Study Links Inherited Blindness to Gene Tied to Rare Metabolic Disorder
11 Nov 2003  |   BioResearch

Population-Scale Proteomics Study Identifies New Genetic-Protein Links
11 Nov 2003  |   BioResearch

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
11 Nov 2003  |   BioResearch